Moexipril

Moexipril (marketed under the tradenames Univasc and Perdix) is an ACE inhibitor.

Also known as:

  • Univasc,
  • Perdix

Facts from the Community

From the BioVenturist base

Indication or disease:

Disease Phase of development

Technology involved:

Developed by:

Brand Names:

  • Perdix
  • Univasc

Stage of development:

top ↑

We can tell you that Moexipril is a…

If you know more about Moexipril, you can add more facts here »

You can help improve this topic by adding more facts here

Edit this topic
Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!

Freebase Attribution

Freebase data is free for use under the CC-BY license.

The original description for Moexipril was automatically generated from Wikipedia.org licensed under the GNU Free Documentation License.
[1]
Learn more about Freebase licensing and attribution